Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

US Airways Group, Inc. (LCC), AMR Merger: Strike Ball?

US Airways Group Inc (LCC)US Airways Group, Inc. (NYSE:LCC) and AMR are reported to be making progress towards the much anticipated merger between the two to create the world’s largest airline.

Pressured by creditors, AMR’s CEO, Tom Horton, is serious about the merger. At first, Horton believed American Airlines would be able to successfully navigate through the bankruptcy on its own but has come under pressure from AMR’s bondholders and has agreed to consider all options. Unfortunately, these options are not many as there is no other suitor for AMR Corporation.

According to reports, the combined entity would be headed by U.S. Airways’ Chief Executive Doug Parker while AMR’s Tom Horton would become non-executive chairman of the board.

Horton is expected to remain on the scene until the transition is completed. The transaction, likely to involve stock but no cash, values the combined entity at $11 billion – enough to put it ahead of United Continental Holdings Inc(NYSE:UAL).

The combined carrier would still be behind Delta Air Lines, Inc. (NYSE:DAL) which has over $12.5 billion in terms of market capitalization. Under the terms of the deal, AMR creditors would get to own 72 percent of the new company while the remaining will rest with AMR shareholders.

Enough has already been written about the benefits of the merger and how the combined entity will have little overlap and would enjoy synergies anywhere between $1 billion and $2 billion annually.

What retail investors need to know is if there is a way to benefit from the deal and if yes, how? Unfortunately, the hailed transaction falls flat in this department. Investors should be cautious regarding AMR’s inflated share price. The shares are up nearly threefold over the past quarter, and these shares are not likely to find a place in the larger scheme of things.

From the standpoint of buying US Airways Group, Inc. (NYSE:LCC) stock, the story of leveraging synergies will unfold over a longer term and will be subject to several operational issues, including the whole integration exercise. The stock is already up substantially and is trading close to its 52 week high. Considering the vastly improved results the company has posted in the recent quarters, this is justified but simultaneously opens a downside too.

As many experts reckon, mergers and acquisitions face many unknown challenges during the integration of operations. The downside for U.S. Airways shares, which are already flying high, could easily be bigger than the potential gains. The company has impressed with its standalone performance. For the fourth quarter ended December 31 (one of the slowest in a year) – US Airways reported a 4% increase in operating revenues, while net income more than doubled to $37 million. For the full year, US Airways had a 6% increase in revenues to $3.9 billion, while net income soared from $180 million to $702 million.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.